1072-93-1
Chemical Structure
Epigoitrin
- CAS No.: 1072-93-1
- Formula:C5H7NOS
- Molecular Weight:129.18
IUPAC Name: (R)-5-vinyloxazolidine-2-thione
InChIKey: UZQVYLOFLQICCT-SCSAIBSYSA-N
SMILES: S=C1O[C@H](C=C)CN1
Biological Activity: Epigoitrin is a natural alkaloid that provides protection against influenza infection by reducing the host’s susceptibility to influenza virus under stress. Epigoitrin exerts antiviral activity against influenza A1 virus FM1 via inhibiting virus attachment and multiplication in vitro. Epigoitrin also has lipid-lowering effects[1][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Epigoitrin | 99.91% | Epigoitrin is a natural alkaloid that provides protection against influenza infection by reducing the host’s susceptibility to influenza virus under stress. Epigoitrin exerts antiviral activity against influenza A1 virus FM1 via inhibiting virus attachment and multiplication in vitro. Epigoitrin also has lipid-lowering effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Epigoitrin (Standard) | ≥98% | Epigoitrin (Standard) is the analytical standard of Epigoitrin. This product is intended for research and analytical applications. Epigoitrin is a natural alkaloid that provides protection against influenza infection by reducing the host’s susceptibility to influenza virus under stress. Epigoitrin exerts antiviral activity against influenza A1 virus FM1 via inhibiting virus attachment and multiplication in vitro. Epigoitrin also has lipid-lowering effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Luo Z, et al. Epigoitrin, an Alkaloid From Isatis indigotica, Reduces H1N1 Infection in Stress-Induced Susceptible Model in vivo and in vitro. Front Pharmacol. 2019 Feb 7;10:78. [Content Brief]
- [3]. Li M, et al. Epigoitrin alleviates lipid and glucose metabolic disorders induced by a high-fat diet. Food Funct. 2022 Jul 4;13(13):7260-7273. [Content Brief]
Keywords